Acutaas Chemicals Ltd Q1 FY27 Results Analysis: PAT Surges 68%, Margin Compresses 811 bps QoQ
Acutaas Chemicals Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 329.67 Cr (+59.08% YoY) and PAT growth of +67.67% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | July 24, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Revenue (Q1) | Rs. 329.67 Cr (+59.08% YoY) |
| PAT (Q1) | Rs. 74.26 Cr (+67.67% YoY) |
| EBITDA margin | 34.30% (+974 bps YoY) |
| EPS (Q1) | Rs. 9.07 (+67.65% YoY) |
| Market cap | Rs. 26,710.60 Cr |
| CMP | Rs. 3,259.50 |
Quarter Snapshot
ACUTAAS delivered strong YoY revenue growth of 59% and PAT growth of 68%, with EBITDA margin expanding 974 bps YoY. However, the quarter saw a sharp sequential decline of 24% in revenue and an 811 bps QoQ margin compression, driven by higher raw material costs and employee expenses. No management guidance or forward-looking commentary was provided, limiting visibility on future trajectory.
Key Investment Insights
Key Positives
- Consolidated revenue grew 59.08% YoY to Rs.329.67 Cr from Rs.207.24 Cr in Q1FY26
- PAT (owners) grew 67.67% YoY to Rs.74.26 Cr from Rs.44.29 Cr
- EBITDA margin expanded 974 bps YoY to 34.30% from 24.56%
- EBITDA grew 122.10% YoY to Rs.113.07 Cr from Rs.50.91 Cr
- Effective tax rate remains moderate at 27.83%
Risk Factors
- Revenue declined 23.82% QoQ from Rs.432.75 Cr in Q4FY26, a sharp sequential drop
- EBITDA margin compressed 811 bps QoQ from 42.41% to 34.30%
- Cost of materials as % of revenue rose 8pp QoQ to 50.28%, pressuring gross margins
- Employee benefits expense grew 18.86% QoQ, indicating rising fixed cost base from capex expansion
Ask about this
Ask Cofacto a question about this result. Answers cite filings and company data.
Related
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.